This cutting-edge GLP-1 mimicking drug increases insulin production, impacts blood sugar, and supports a healthy metabolismall while significantly reducing your hunger and cravings
There is currently no effective cure, but the condition can be effectively managed through lifestyle changes, medications, and sometimes insulin therapy
The drug is administered once weekly via subcutaneous injection, with dosing typically starting at 2.5 mg and gradually increasing every 4 weeks as tolerated through 5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg based on individual response and tolerability
Pathological manifestations include thickening of the glomerular basement membrane, progressive loss of podocytes, and dilatation of the renal interstitial matrix
If nausea doesn't improve after adjusting timing and strategies, contact your provider to discuss whether your dose needs to be reduced
Supplementary Material 3 Protein Quantification and Differential Analysis List